Entecavir
- 1 July 2005
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 4 (7) , 535-536
- https://doi.org/10.1038/nrd1780
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Determining the extent of quality health care for hospitalized patients with cirrhosis †Hepatology, 2005
- Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental modelsJournal of Antimicrobial Chemotherapy, 2005
- Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year studyJournal of Hepatology, 2005
- Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failureJournal of Hepatology, 2005
- Treatment of chronic hepatitis B: Who to treat, what to use, and for how long?Clinical Gastroenterology and Hepatology, 2004
- Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infectionAntiviral Research, 2004
- Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infectionAntiviral Research, 2004
- 42 Results of a one-year international phase IIB trial of LDT, and LDT plus lamivudine, in patients with chronic hepatitis BJournal of Hepatology, 2004
- Emtricitabine/Tenofovir Disoproxil FumarateDrugs, 2004
- Potent Efficacy of Entecavir (BMS-200475) in a Duck Model of Hepatitis B Virus ReplicationAntimicrobial Agents and Chemotherapy, 2002